Myomo Inc (MYO) - Total Liabilities

Latest as of March 2026: $27.75 Million USD

Based on the latest financial reports, Myomo Inc (MYO) has total liabilities worth $27.75 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Myomo Inc (MYO) cash conversion ratio to assess how effectively this company generates cash.

Myomo Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Myomo Inc's total liabilities have evolved over time, based on quarterly financial data. Check MYO asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Myomo Inc Competitors by Total Liabilities

The table below lists competitors of Myomo Inc ranked by their total liabilities.

Company Country Total Liabilities
RedCloud Holdings plc Ordinary Shares
NASDAQ:RCT
USA $21.41 Million
Quonia SOCIMI SA
MC:YQUO
Spain €11.63 Million
Viomi Technology ADR
NASDAQ:VIOT
USA $1.38 Billion
GeneReach Biotechnology
TWO:4171
Taiwan NT$284.34 Million
Samhwa Crown
KO:004450
Korea ₩101.43 Billion
Good Way Technology Co Ltd
TWO:3272
Taiwan NT$3.64 Billion
Toplus Global Co Ltd
TWO:3522
Taiwan NT$1.69 Billion
Dongil Metal Co. Ltd
KQ:109860
Korea ₩24.74 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Myomo Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Myomo Inc (MYO) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.73 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.76 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Myomo Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Myomo Inc (2014–2025)

The table below shows the annual total liabilities of Myomo Inc from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 $27.23 Million +55.35%
2024-12-31 $17.53 Million +213.47%
2023-12-31 $5.59 Million +47.06%
2022-12-31 $3.80 Million -18.86%
2021-12-31 $4.69 Million +49.04%
2020-12-31 $3.14 Million -34.13%
2019-12-31 $4.77 Million +157.26%
2018-12-31 $1.86 Million +21.35%
2017-12-31 $1.53 Million -92.03%
2016-12-31 $19.19 Million +573.99%
2015-12-31 $2.85 Million +22.03%
2014-12-31 $2.33 Million --

About Myomo Inc

NYSE MKT:MYO USA Medical Devices
Market Cap
$36.71 Million
Market Cap Rank
#23501 Global
#4982 in USA
Share Price
$0.95
Change (1 day)
+3.85%
52-Week Range
$0.64 - $3.14
All Time High
$579.30
About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more